PMS28 Cost-Benefit-Analysis of Thromboprophylaxis With Rivaroxaban and Certoparin-Sodium in Patients After Total Hip or Knee Replacement
Value in Health- United Kingdom
doi 10.1016/j.jval.2012.08.1383
Full Text
Abstract
Available in
Date
November 1, 2012
Authors
Publisher
Elsevier BV